NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: AI Tool BRIDGE for Presurgical Breast Cancer Treatment
BRIDGE is a new AI tool developed at Cedars-Sinai that analyzes genetic signals within a tumor to identify subtypes and predict the best presurgical therapy for breast cancer patients. This approach aims to improve treatment selection by considering tumor heterogeneity rather than assigning a single category.
BRIDGE is an AI tool developed at Cedars-Sinai that reads genetic signals in a tumor to identify subtypes and predict the most suitable presurgical treatment for breast cancer patients.
Instead of classifying the whole tumor as one subtype, BRIDGE analyzes the genetic signals within the tumor to identify multiple coexisting subtypes, providing a more personalized treatment recommendation.
BRIDGE was developed at Cedars-Sinai and detailed in the journal Annals of Oncology alongside early validation data.
Breast cancer patients could benefit from BRIDGE as it helps doctors select the optimal presurgical therapy tailored to the specific subtypes present in the tumor.
BRIDGE improves treatment selection by accounting for tumor heterogeneity, potentially leading to better outcomes and more effective presurgical therapies.
The content mentions early validation data, but does not specify if BRIDGE is in routine clinical use.